Research never stops

Top Story

Evotec AG increases its profitability guidance for 2016

Hamburg, Germany, 19 July 2016: Evotec AG today announced that, in the context of the half year results published on 10 August 2016, it increases its financial guidance for the current year.

- read more

Evotec awarded contract from Antibiotic Research UK to begin integrated drug discovery collaboration

Hamburg, Germany, 11 July 2016: Evotec AG announced today a collaboration with Antibiotic Research UK to identify alternative means of treating infections that are resistant to currently available antibiotics.

- read more

Evotec enters license agreement for access to CRISPR-Cas9 gene editing technology

Hamburg, Germany, 06 July 2016: Evotec AG announced today that the Company has entered into a non-exclusive licence agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology.

- read more
loading weather report
Loading weather report...


Aug 30, 2016 - Preclinical and Translational Immuno-Oncology

Sep 12, 2016 - Morgan Stanley Global Healthcare Conference

Company Presentation July

Building integrated and high-value drug discovery alliances
2016-07_Evotec_Company presentation_July